Open AccessPrior Treatment for Non–small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy
Author(s) -
Mark Farrugia,
Sung Jun,
Mark Hen,
Chukwumere Nwogu,
Elisabeth U. Dexter,
Anthony Picone,
Todd L. Demmy,
Jorge A. Gomez-Suescun,
Simon Fung-Kee-Fung,
Sai Yendamuri,
Anurag Singh
Publication year - 2020
Publication title -
american journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.896
H-Index - 78
eISSN - 1537-453X
pISSN - 0277-3732
DOI - 10.1097/coc.0000000000000778
Subject(s) - medicine , lung cancer , proportional hazards model , oncology , hazard ratio , univariate analysis , stage (stratigraphy) , malignancy , cohort , radiosurgery , survival analysis , radiation therapy , multivariate analysis , cancer , confidence interval , paleontology , biology
Despite occurring commonly, the prognoses of second early-stage non-small cell lung cancers (NSCLC) are not well known.